Evidence map›Paper›PMID 39206357›Full record

ArticlePhysics and imaging in radiation oncology2024

Balancing benefits and limitations of linear energy transfer optimization in carbon ion radiotherapy for large sacral chordomas.

Giovanni Parrella, Giuseppe Magro, Agnieszka Chalaszczyk, Marco Rotondi, Mario Ciocca, Lars Glimelius, Maria R Fiore, Chiara Paganelli, Ester Orlandi, Silvia Molinelli and 1 more

Abstract read
In one paragraph

Article in Physics and imaging in radiation oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Giovanni ParrellaDepartment of Electronics, Information and Bioengineering, Politecnico di Milano, Via G.Ponzio 34/5, 20133 Milan, Italy.
Giuseppe MagroMedical Physics Unit, National Center of Oncological Hadrontherapy (CNAO), Strada Campeggi, 53, 11 27100 Pavia, Italy.
Agnieszka ChalaszczykRadiotherapy Unit, National Center of Oncological Hadrontherapy (CNAO), Strada Campeggi, 53, 11 27100 Pavia, Italy.
Marco RotondiRaysearch Laboratories, Eugeniavägen 18, 113 68 Stockholm, Sweden.
Mario CioccaMedical Physics Unit, National Center of Oncological Hadrontherapy (CNAO), Strada Campeggi, 53, 11 27100 Pavia, Italy.
Lars GlimeliusRaysearch Laboratories, Eugeniavägen 18, 113 68 Stockholm, Sweden.
Maria R FioreRadiotherapy Unit, National Center of Oncological Hadrontherapy (CNAO), Strada Campeggi, 53, 11 27100 Pavia, Italy.
Chiara PaganelliDepartment of Electronics, Information and Bioengineering, Politecnico di Milano, Via G.Ponzio 34/5, 20133 Milan, Italy.
Ester OrlandiDepartment of Clinical, Surgical, Diagnostic and Pediatric Sciences, University of Pavia, Via A. Brambilla 74, 27100 Pavia, Italy.
Silvia MolinelliMedical Physics Unit, National Center of Oncological Hadrontherapy (CNAO), Strada Campeggi, 53, 11 27100 Pavia, Italy.
Guido BaroniDepartment of Electronics, Information and Bioengineering, Politecnico di Milano, Via G.Ponzio 34/5, 20133 Milan, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and Purpose: A low linear energy transfer (LET) in the target can reduce the effectiveness of carbon ion radiotherapy (CIRT). This study aimed at exploring benefits and limitations of LET optimization for large sacral chordomas (SC) undergoing CIRT. Materials and Methods: Seventeen cases were used to tune LET-based optimization, and seven to independently test interfraction plan robustness. For each patient, a reference plan was optimized on biologically-weighted dose cost functions. For the first group, 7 LET-optimized plans were obtained by increasing the gross tumor volume (GTV) minimum LET Results: GTV L Conclusion: LET

Indexed as

Carbon Ion RadiotherapyLET optimizationSacral Chordomas

Identifiers

PMID39206357
PMCPMC11357807

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.